NCT00658541View on ClinicalTrials.gov

Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
HealthyTherapeutic Equivalency
Interventions
DRUG

Zolpidem Tartrate 10 mg tablet

10 mg tablet administered following an overnight fast of at least 10 hours and a standardized, high fat breakfast.

DRUG

Zolpidem Tartrate 10 mg tablet (Ambien®)

10 mg tablet administered following an overnight fast of at least 10 hours and a standardized, high fat breakfast.

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00658541 - Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets | Biotech Hunter | Biotech Hunter